MIS-C sequel to COVID-19 infection, diagnostic challenge and management. A case report

Authors

  • Subash Paudeal 2nd Year Resident, MD Pediatrics, Patan Academy of Health Sciences, Lalitpur, Nepal.
  • Sunil Kumar Das 2nd Year Resident, MD General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lalitpur Nepal.

Keywords:

COVID-19, diagnosis, MISC-C

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a rare sequel to severe acute respiratory syndrome coronavirus (SARS-CoV-2). Clinical picture of MIS-C includes multi system inflammation alongside fever and severe illness with laboratory evidence of raised inflammatory markers. MIS-C may resemble toxic shock syndrome, complete or incomplete Kawasaki disease and macrophage activation syndrome. Actual management of MIS-C is yet to be formulated, currently treatment is supportive only. In addition, as MIS-C is a new clinical entity we do not know about its long-term prognosis.

Downloads

Download data is not yet available.
Abstract
0
PDF
0

Downloads

Published

2021-07-01

How to Cite

Paudeal, S., & Das, S. K. (2021). MIS-C sequel to COVID-19 infection, diagnostic challenge and management. A case report. Journal of General Practice and Emergency Medicine of Nepal, 8(11), 55–58. Retrieved from https://nepjol.info/index.php/jgpemn/article/view/89639

Issue

Vol. 8 No. 11 (2021)

Section

Case Reports/Case Series

License

Copyright (c) 2021 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.